Exact Mass: 487.239
Exact Mass Matches: 487.239
Found 500 metabolites which its exact mass value is equals to given mass value 487.239
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ac-Ser-Asp-Lys-Pro-OH
Ac-Ser-Asp-Lys-Pro-OH, also known as Ac-ser-asp-lys-pro or AcSDKP-NH2, is classified as a member of the Oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Ac-Ser-Asp-Lys-Pro-OH is considered to be practically insoluble (in water) and acidic D020011 - Protective Agents > D011837 - Radiation-Protective Agents D006133 - Growth Substances > D006131 - Growth Inhibitors C26170 - Protective Agent
Acetyl-Ser-Asp-Lys-Pro
D020011 - Protective Agents > D011837 - Radiation-Protective Agents D006133 - Growth Substances > D006131 - Growth Inhibitors
Y1 Receptor antagonist 1
16,17-didehydro-isomigrastatin|16,17-didehydroisomigrastatin
C27H37NO7_Spiro[2H-furo[2,3-e]isoindole-2,1(2H)-naphthalene]-7(3H)-butanoic acid, 3,4,4a,5,6,6,7,8,8,8a-decahydro-4,6,7-trihydroxy-2,5,5,8a-tetramethyl-6-oxo-, (2R,2R,6S,7R,8aS)
4-[[4-hydroxy-2-(2-methylpropyl)-1-oxo-3,3a-dihydro-2H-imidazo[1,2-a]indol-4-yl]methyl]-1-methyl-2,4-dihydro-1H-pyrazino[2,1-b]quinazoline-3,6-dione
Ala Phe His Asn
Ala Phe Asn His
Ala His Phe Asn
Ala His Asn Phe
Ala Asn Phe His
Ala Asn His Phe
Ala Asn Gln Arg
Ala Asn Arg Gln
Ala Gln Asn Arg
Ala Gln Arg Asn
Ala Arg Asn Gln
Ala Arg Gln Asn
Cys His Lys Thr
Cys His Thr Lys
Cys Ile Pro Arg
Cys Ile Arg Pro
Cys Lys His Thr
Cys Lys Thr His
Cys Leu Pro Arg
Cys Leu Arg Pro
Cys Pro Ile Arg
Cys Pro Leu Arg
Cys Pro Arg Ile
Cys Pro Arg Leu
Cys Arg Ile Pro
Cys Arg Leu Pro
Cys Arg Pro Ile
Cys Arg Pro Leu
Cys Thr His Lys
Cys Thr Lys His
Asp Glu Lys Pro
Asp Glu Pro Lys
Asp Lys Glu Pro
Asp Lys Pro Glu
Asp Pro Glu Lys
Asp Pro Lys Glu
Asp Pro Arg Thr
Asp Pro Thr Arg
Asp Arg Pro Thr
Asp Arg Thr Pro
Asp Thr Pro Arg
Asp Thr Arg Pro
Glu Asp Lys Pro
Glu Asp Pro Lys
Glu Lys Asp Pro
Glu Lys Pro Asp
Glu Pro Asp Lys
Glu Pro Lys Asp
Glu Pro Arg Ser
Glu Pro Ser Arg
Glu Arg Pro Ser
Glu Arg Ser Pro
Glu Ser Pro Arg
Glu Ser Arg Pro
Phe Ala His Asn
Phe Ala Asn His
Phe Gly His Lys
Phe Gly His Gln
Phe Gly Lys His
Phe Gly Gln His
Phe His Ala Asn
Phe His Gly Lys
Phe His Gly Gln
Phe His Lys Gly
Phe His Asn Ala
Phe His Gln Gly
Phe Lys Gly His
Phe Lys His Gly
Phe Asn Ala His
Phe Asn His Ala
Phe Pro Pro Gln
Phe Pro Gln Pro
Phe Gln Gly His
Phe Gln His Gly
Phe Gln Pro Pro
Gly Phe His Lys
Gly Phe His Gln
Gly Phe Lys His
Gly Phe Gln His
Gly His Phe Lys
Gly His Phe Gln
Gly His Lys Phe
Gly His Gln Phe
Gly Lys Phe His
Gly Lys His Phe
Gly Gln Phe His
Gly Gln His Phe
Gly Gln Gln Arg
Gly Gln Arg Gln
Gly Arg Gln Gln
His Ala Phe Asn
His Ala Asn Phe
His Cys Lys Thr
His Cys Thr Lys
His Phe Ala Asn
His Phe Gly Lys
His Phe Gly Gln
His Phe Lys Gly
His Phe Asn Ala
His Phe Gln Gly
His Gly Phe Lys
His Gly Phe Gln
His Gly Lys Phe
His Gly Gln Phe
His Lys Cys Thr
His Lys Phe Gly
His Lys Gly Phe
His Lys Thr Cys
His Asn Ala Phe
His Asn Phe Ala
His Gln Phe Gly
His Gln Gly Phe
His Thr Cys Lys
His Thr Lys Cys
Ile Cys Pro Arg
Ile Cys Arg Pro
Ile Met Pro Gln
Ile Met Gln Pro
Ile Asn Asn Gln
Ile Asn Gln Asn
Ile Pro Cys Arg
Ile Pro Met Gln
Ile Pro Gln Met
Ile Pro Arg Cys
Ile Gln Met Pro
Ile Gln Asn Asn
Ile Gln Pro Met
Ile Arg Cys Pro
Ile Arg Pro Cys
Lys Cys His Thr
Lys Cys Thr His
Lys Asp Glu Pro
Lys Asp Pro Glu
Lys Glu Asp Pro
Lys Glu Pro Asp
Lys Phe Gly His
Lys Phe His Gly
Lys Gly Phe His
Lys Gly His Phe
Lys His Cys Thr
Lys His Phe Gly
Lys His Gly Phe
Lys His Thr Cys
Lys Pro Asp Glu
Lys Pro Glu Asp
Lys Thr Cys His
Lys Thr His Cys
Leu Cys Pro Arg
Leu Cys Arg Pro
Leu Met Pro Gln
Leu Met Gln Pro
Leu Asn Asn Gln
Leu Asn Gln Asn
Leu Pro Cys Arg
Leu Pro Met Gln
Leu Pro Gln Met
Leu Pro Arg Cys
Leu Gln Met Pro
Leu Gln Asn Asn
Leu Gln Pro Met
Leu Arg Cys Pro
Leu Arg Pro Cys
Met Ile Pro Gln
Met Ile Gln Pro
Met Leu Pro Gln
Met Leu Gln Pro
Met Pro Ile Gln
Met Pro Leu Gln
Met Pro Gln Ile
Met Pro Gln Leu
Met Gln Ile Pro
Met Gln Leu Pro
Met Gln Pro Ile
Met Gln Pro Leu
Asn Ala Phe His
Asn Ala His Phe
Asn Ala Gln Arg
Asn Ala Arg Gln
Asn Phe Ala His
Asn Phe His Ala
Asn His Ala Phe
Asn His Phe Ala
Asn Ile Asn Gln
Asn Ile Gln Asn
Asn Leu Asn Gln
Asn Leu Gln Asn
Asn Asn Ile Gln
Asn Asn Leu Gln
Asn Asn Gln Ile
Asn Asn Gln Leu
Asn Gln Ala Arg
Asn Gln Ile Asn
Asn Gln Leu Asn
Asn Gln Asn Ile
Asn Gln Asn Leu
Asn Gln Gln Val
Asn Gln Arg Ala
Asn Gln Val Gln
Asn Arg Ala Gln
Asn Arg Gln Ala
Asn Val Gln Gln
Pro Cys Ile Arg
Pro Cys Leu Arg
Pro Cys Arg Ile
Pro Cys Arg Leu
Pro Asp Glu Lys
Pro Asp Lys Glu
Pro Asp Arg Thr
Pro Asp Thr Arg
Pro Glu Asp Lys
Pro Glu Lys Asp
Pro Glu Arg Ser
Pro Glu Ser Arg
Pro Phe Pro Gln
Pro Phe Gln Pro
Pro Ile Cys Arg
Pro Ile Met Gln
Pro Ile Gln Met
Pro Ile Arg Cys
Pro Lys Asp Glu
Pro Lys Glu Asp
Pro Leu Cys Arg
Pro Leu Met Gln
Pro Leu Gln Met
Pro Leu Arg Cys
Pro Met Ile Gln
Pro Met Leu Gln
Pro Met Gln Ile
Pro Met Gln Leu
Pro Pro Phe Gln
Pro Pro Gln Phe
Pro Gln Phe Pro
Pro Gln Ile Met
Pro Gln Leu Met
Pro Gln Met Ile
Pro Gln Met Leu
Pro Gln Pro Phe
Pro Arg Cys Ile
Pro Arg Cys Leu
Pro Arg Asp Thr
Pro Arg Glu Ser
Pro Arg Ile Cys
Pro Arg Leu Cys
Pro Arg Ser Glu
Pro Arg Thr Asp
Pro Ser Glu Arg
Pro Ser Arg Glu
Pro Ser Val Trp
Pro Ser Trp Val
Pro Thr Asp Arg
Pro Thr Arg Asp
Pro Val Ser Trp
Pro Val Trp Ser
Pro Trp Ser Val
Pro Trp Val Ser
Gln Ala Asn Arg
Gln Ala Arg Asn
Gln Phe Gly His
Gln Phe His Gly
Gln Phe Pro Pro
Gln Gly Phe His
Gln Gly His Phe
Gln Gly Gln Arg
Gln Gly Arg Gln
Gln His Phe Gly
Gln His Gly Phe
Gln Ile Met Pro
Gln Ile Asn Asn
Gln Ile Pro Met
Gln Leu Met Pro
Gln Leu Asn Asn
Gln Leu Pro Met
Gln Met Ile Pro
Gln Met Leu Pro
Gln Met Pro Ile
Gln Met Pro Leu
Gln Asn Ala Arg
Gln Asn Ile Asn
Gln Asn Leu Asn
Gln Asn Asn Ile
Gln Asn Asn Leu
Gln Asn Gln Val
Gln Asn Arg Ala
Gln Asn Val Gln
Gln Pro Phe Pro
Gln Pro Ile Met
Gln Pro Leu Met
Gln Pro Met Ile
Gln Pro Met Leu
Gln Pro Pro Phe
Gln Gln Gly Arg
Gln Gln Asn Val
Gln Gln Arg Gly
Gln Gln Val Asn
Gln Arg Ala Asn
Gln Arg Gly Gln
Gln Arg Asn Ala
Gln Arg Gln Gly
Gln Val Asn Gln
Gln Val Gln Asn
Arg Ala Asn Gln
Arg Ala Gln Asn
Arg Cys Ile Pro
Arg Cys Leu Pro
Arg Cys Pro Ile
Arg Cys Pro Leu
Arg Asp Pro Thr
Arg Asp Thr Pro
Arg Glu Pro Ser
Arg Glu Ser Pro
Arg Gly Gln Gln
Arg Ile Cys Pro
Arg Ile Pro Cys
Arg Leu Cys Pro
Arg Leu Pro Cys
Arg Asn Ala Gln
Arg Asn Gln Ala
Arg Pro Cys Ile
Arg Pro Cys Leu
Arg Pro Asp Thr
Arg Pro Glu Ser
Arg Pro Ile Cys
Arg Pro Leu Cys
Arg Pro Ser Glu
Arg Pro Thr Asp
Arg Gln Ala Asn
Arg Gln Gly Gln
Arg Gln Asn Ala
Arg Gln Gln Gly
Arg Ser Glu Pro
Arg Ser Pro Glu
Arg Thr Asp Pro
Arg Thr Pro Asp
Ser Glu Pro Arg
Ser Glu Arg Pro
Ser Pro Glu Arg
Ser Pro Arg Glu
Ser Pro Val Trp
Ser Pro Trp Val
Ser Arg Glu Pro
Ser Arg Pro Glu
Ser Val Pro Trp
Ser Val Trp Pro
Ser Trp Pro Val
Ser Trp Val Pro
Thr Cys His Lys
Thr Cys Lys His
Thr Asp Pro Arg
Thr Asp Arg Pro
Thr His Cys Lys
Thr His Lys Cys
Thr Lys Cys His
Thr Lys His Cys
Thr Pro Asp Arg
Thr Pro Arg Asp
Thr Arg Asp Pro
Thr Arg Pro Asp
Val Asn Gln Gln
Val Pro Ser Trp
Val Pro Trp Ser
Val Gln Asn Gln
Val Gln Gln Asn
Val Ser Pro Trp
Val Ser Trp Pro
Val Trp Pro Ser
Val Trp Ser Pro
Trp Pro Ser Val
Trp Pro Val Ser
Trp Ser Pro Val
Trp Ser Val Pro
Trp Val Pro Ser
Trp Val Ser Pro
(1-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-{[(1-{[(2-methyl-2-prop anyl)oxy]carbonyl}-4-piperidinyl)carbonyl]amino}-1H-indol-2-yl)bo ronic acid
3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tritylpyrazolo[3,4-b]pyridine
Valemetostat
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor
(2E,11R)-11-{[3,6-dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy}dodec-2-enoic acid
(1S,4Z,7R,9R)-9-(2-methylbut-3-en-2-yl)-4-[[1-(2-methyl-4-oxopentan-2-yl)imidazol-4-yl]methylidene]-2,5,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-10,12,14-triene-3,6-dione
sodium(E)-((1R,4aS,4bS,8aS,10aS)-4b,8,8,10a-tetramethyl-1-(2-(2-oxo-2,5-dihydro-1H-pyrrol-3-yl)ethyl)decahydrophenanthren-2(1H,3H,4bH)-ylidene)methyl sulfate
A natural product found in Coscinoderma species.
(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoic acid
(2S)-2-[[[4-[[4-[[[(2-methylpropan-2-yl)oxy-oxomethyl]amino]methyl]anilino]-oxomethyl]-1H-imidazol-5-yl]-oxomethyl]amino]propanoic acid tert-butyl ester
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
(6S,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
(2S)-2-[(4R,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
(1R,9S,10S,11S)-12-(cyclobutanecarbonyl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-12-benzoyl-5-(cyclopenten-1-yl)-N-cyclopentyl-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-3-ylacetamide
(2R)-2-[(4S,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
(2R)-2-[(4R,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-[[methyl(2-pyridinylmethyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyridin-2-ylacetamide
3,3,3-trifluoro-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(1-oxopropyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
(6S,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzamide
N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylpyridine-4-carboxamide
(1S,9R,10R,11R)-12-(cyclobutanecarbonyl)-N-(cyclopropylmethyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-12-benzoyl-5-(cyclopenten-1-yl)-N-cyclopentyl-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-[(1R)-1-benzoyl-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-2-cyclopropylethanone
(6R,7S,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7S,8R)-7-[4-(3-cyclopentylprop-1-ynyl)phenyl]-8-(hydroxymethyl)-N-(3-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate
goralatide
D020011 - Protective Agents > D011837 - Radiation-Protective Agents D006133 - Growth Substances > D006131 - Growth Inhibitors C26170 - Protective Agent
LP44 (hydrochloride)
LP44 (hydrochloride) is a selective 5-HT7 agonist with Ki of 0.22 nM. LP44 (hydrochloride) induces hypothermic effect in a dose-dependent manner by intracerebroventricular injection. LP44 (hydrochloride) not causes considerable hypothermic response by intraperitoneal administration[1].